MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
March 6, 2006
Stephen D. Simpson
Integra Integrates Higher Revenue High rewards will match high expectations -- if the medical device company delivers. Investors, take note. mark for My Articles similar articles
The Motley Fool
November 3, 2006
Matthew Crews
Integra's Value of Growth Whenever a company earns less than its cost of capital, it destroys value. No amount of adjustments can hide the simple fact that Integra is unable to create value for its shareholders. mark for My Articles similar articles
The Motley Fool
February 21, 2007
Rich Duprey
Foolish Forecast: Adding to Integra LifeSciences The med-tech company is set to report fourth-quarter 2006 earnings. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
August 2, 2006
Stephen D. Simpson
Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 27, 2011
Integra LifeSciences Holdings Earnings Preview Integra LifeSciences Holdings will unveil its latest earnings Thursday. mark for My Articles similar articles
The Motley Fool
October 31, 2011
Travis Hoium
Integra LifeSciences Shares Dropped: What You Need to Know Shares of medical device maker Integra LifeSciences fell 14% today after the company released earnings and cut its full-year forecast. mark for My Articles similar articles
The Motley Fool
January 6, 2012
Sean Williams
Integra LifeSciences Shares Plunged: What You Need to Know Shareholders of medical device maker Integra LifeSciences are falling off their second cliff in as many quarters, down 17%, after the company issued disappointing preliminary fourth-quarter and full-year guidance. mark for My Articles similar articles
The Motley Fool
October 25, 2007
Billy Fisher
Plenty of Strength in Zimmer Orthopedic manufacturer Zimmer Holdings reports a solid third quarter, but lowers its forecast for Q4. mark for My Articles similar articles
The Motley Fool
October 31, 2005
Stephen D. Simpson
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. mark for My Articles similar articles
The Motley Fool
March 1, 2007
Sewing Up Integra Lifesciences: Fool by Numbers The medical-device specialist released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
May 9, 2005
Stephen D. Simpson
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. mark for My Articles similar articles
The Motley Fool
May 27, 2011
Andrew Tonner
Does Zimmer Holdings Deserve a Spot in Your Portfolio? Compared to it's peers, Zimmer Holdings doesn't look like a stock for your portfolio right now. mark for My Articles similar articles
The Motley Fool
March 6, 2006
Stephen D. Simpson
Integrating Integra's Numbers: Fool by Numbers Integra LifeSciences released fourth-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
November 3, 2006
Integra's Improving Revenues: Fool by Numbers Integra LifeSciences released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 25, 2010
Rick Aristotle Munarriz
3 Stocks That Blew the Market Away Intuitive Surgical... eBay... Google... mark for My Articles similar articles
The Motley Fool
July 28, 2005
Stephen D. Simpson
Zimmer at a Simmer Strong demand for reconstructive products keeps this orthopedics company limber. Zimmer's 30-plus trailing price-to-earnings ratio still looks high, but it is in line with this industry's current multiples. mark for My Articles similar articles